Von Willebrand Disease
New von Willebrand disease study findings recently were published by J.L. Diener and co-researchers
Published in Pharma Law Weekly, August 11th, 2009
"This initial platelet binding event stimulates platelet activation, recruitment, and activation of the clotting cascade, promoting thrombus formation. To characterize the inhibitory activity of a VWF inhibitory aptamer. Using in vitro selection, aptamer stabilization, and conjugation to a 20-kDa poly(ethylene glycol), we generated a nuclease-resistant aptamer, ARC1779, that binds to the VWF A1-domain...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Law Weekly
Source: Pharma Law Weekly (2009-08-11)
More Articles from Pharma Law Weekly
- Aesyntix Health, Inc.
Aesyntix Physician Network Signs Exclusive Contract with Wholesale Merchant Group for Merchant Processing Services - Aging
Department of Aging Urges Citizens to Report Abuse and Neglect of Older Adults - Alcohol and Alcoholism
Research from J.C. Fell and co-authors reveals new findings on alcohol and alcoholism - American Center for Law and Justice
ACLJ: 65,000 Americans Sign Petition Demanding Congress Exclude Abortion Services from National Health Care Legislation - American Civil Liberties Union
ACLU Drops Community Education Partners from Federal Lawsuit After Atlanta Severs Contract - American Civil Liberties Union
Judge Orders Release of Guantanamo Detainee Mohammed Jawad - More from this issue of Pharma Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
